Form D · Other Health Care

ENT BIOTECH SOLUTIONS, INC.

Grosse Pointe Farms, MI · CIK 0001613649

Offering snapshot reported Apr 25, 2016 · SEC filing

Reported sold: $1.1M
Investors reported: 17
Minimum accepted: $11.7K
First sale: Mar 16, 2015

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$500,000 → $1,100,000
Minimum accepted$7,812 → $11,715

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 25, 2016	Amendment	$1,100,000	$600,000vs Mar 20, 2015	17	SEC filing
Mar 20, 2015	Initial	$500,000	No comparison	17	SEC filing
Jul 14, 2014	Initial	$940,000	No comparison	14	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-236324

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
none	None

Source: Form D, filed Apr 25, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Jack Ball	Director
Jeffery Brinza	Director, Executive
Andrea Roumell Dickson	Director, Executive, Promoter
C. Barthell Dickson	Director, Promoter
Gretchen Knoell	Director
Olivier Lecerf	Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:

75 Lewiston Road
Grosse Pointe Farms, MI, 48236